GLP-1 drugs have been in the news a lot lately. Most recently, Serena Williams went public about taking GLP-1s as part of her weight loss journey. In a nutshell, GLP-1s are a trending topic—and one ...

GLP-1 receptor agonists may reduce the likelihood of mortality and increase odds for transplant wait-listing for patients ...

"For them to work effectively, they need to be taken long term," cautioned epidemiologisy professor Reimar W. Thomsen.

Frontiers in Endocrinology is a contributor to the 2025 Top 10 Emerging Technologies Report launched at the WEF Annual ...

The long haul that Little has committed to could be quite long. Studies have shown that, upon stopping the drug, appetites ...

Patients with rheumatoid arthritis (RA) who used GLP-1 receptor agonists had less disease activity and improved ...

Researchers warn that widespread use of weight-loss drugs like Ozempic among women of reproductive age may pose hidden risks to pregnancy. Flinders University researchers caution that many women using ...

The National Institutes of Health’s flagship long COVID initiative, RECOVER—short for Researching COVID to Enhance ...

Weight-loss drugs (or medicines) are one of the options available for people who want help with weight loss. They work in ...

GLP-1 medications like Ozempic show promise for multiple health conditions, as experts explore microdosing benefits for blood sugar control and longevity.

A study found that GLP-1 drugs are associated with a lower risk of fractures, including hip and osteoporotic fractures. The research, led by scientists from China and published in Acta Diabetologica, ...

Pharmacist professor Luke Grzeskowiak said that these drugs can be useful, but they carry risks, particularly in pregnancy.